The Effect of Veno-Arterial Extracorporeal Oxygenation and Nasogastric Tube Administration on the Pharmacokinetic Profile of Abacavir, Lamivudine and Dolutegravir: A Case Report | Zendy

Alison Blackman | Zendy; Emily L. Heil | Zendy; Aaron S. Devanathan | Zendy; Neha Sheth Pandit | Zendy

Open Access

The Effect of Veno-Arterial Extracorporeal Oxygenation and Nasogastric Tube Administration on the Pharmacokinetic Profile of Abacavir, Lamivudine and Dolutegravir: A Case Report

Author(s) -

Alison Blackman,

Emily L. Heil,

Aaron S. Devanathan,

Neha Sheth Pandit

Publication year - 2019

Publication title -

antiviral therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.747

H-Index - 87

eISSN - 2040-2058

pISSN - 1359-6535

DOI - 10.3851/imp3355

Subject(s) - dolutegravir , medicine , pharmacokinetics , abacavir , lamivudine , extracorporeal membrane oxygenation , anesthesia , pharmacology , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , viral load , hepatitis b virus , virus

Pharmacokinetic (PK) changes can affect antiretroviral (ARV) systemic exposure for critically ill patients living with HIV (CI-PLWH). Studies to guide ARV adjustments in this population are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research